In recent years, the number of patients with chronic kidney disease worldwide has been continuously increasing. Currently, among fatal diseases, the growth rate ranks sixth, and the global disease mortality rate ranks eleventh. The incidence rate of chronic kidney disease in China is as high as 10.8%, and the number of patients is far more than 100 million. The number of end-stage renal disease patients who need renal replacement treatment is more than 1.5 million, and continues to rise at an annual growth rate of 120000-150000. Among them, immune related nephropathy remains the main cause of end-stage renal disease. In this context, the third session of the Kidney Disease Special Diagnosis and Treatment Exchange Conference hosted by Chengdu High tech Medical Association was successfully held online on December 6, 2024. The conference invited relevant experts and scholars to give lectures and exchange ideas, and all relevant experts and scholars participated.